Supplemental Methods

Target Metabolomics
Targeted metabolomics analysis of plasma samples was performed using the Biocrates carbons in the two fatty acids side chains and a single double bond in one of them. Triplicate analysis of plasma samples yielded average coefficient of variance (CV) below 0.09 for the metabolites measured, being the lowest for aminoacids (CV% 0.06) the highest for sphingomyelins (CV% 1.33) . The list of all the measurable metabolites is provided below.
Metabolites measured by MRM-MS
A cy lca r n itin e s 
G ly ce rophos pholipids
lysoP C a C14 :0 PC aa C3 4: 1 P C aa C42 :0 PC a e C3 8:2 lysoP C a C16 :0 PC aa C3 4: 2 P C aa C42 :1 PC a e C3 8:3 lysoP C a C16 :1 PC aa C3 4: 3 P C aa C42 :2 PC a e C3 8:4 lysoP C a C17 :0 PC aa C3 4: 4 P C aa C42 :4 PC a e C3 8:5 lysoP C a C18 :0 PC aa C3 6: 0 P C aa C42 :5 PC a e C3 8:6
lysoP C a C18 :1 PC aa C3 6: 1 P C aa C42 :6 PC a e C4 0:1 lysoP C a C18 :2 PC aa C3 6: 2 P C ae C30 :0 PC a e C4 0:2 lysoP C a C20 :3 PC aa C3 6: 3 P C ae C30 :1 PC a e C4 0:3 lysoP C a C20 :4 PC aa C3 6: 4 P C ae C30 :2 PC a a C4 0:4 lysoP C a C24 :0 PC aa C3 6: 5 P C ae C32 :1 PC a e C4 0:5 lysoP C a C26 :0 PC aa C3 6: 6 P C ae C32 :2 PC a e C4 0:6 lysoP C a C26 :1 PC aa C3 8: 0 P C ae C34 :0 PC a e C4 2:0 lysoP C a C28 :0 PC aa C3 8: 1 P C ae C34 :1 PC a e C4 2:1 lysoP C a C28 :1 PC aa C3 8: 3 P C ae C34 :2 PC a e C4 2:2 PC a a C 2 4:0 PC aa C3 8: 4 P C ae C34 :3 PC a e C4 2:3 PC a a C 2 6:0 PC aa C3 8: 5 P C ae C36 :0 PC a e C4 2:4 PC a a C 2 8:1 PC aa C3 8: 6 P C ae C36 :1 PC a e C4 2:5 PC a a C 3 0:0 PC aa C4 0: 1 P C ae C36 :2 PC a e C4 4:3 PC a a C 3 0:2 PC aa C4 0: 2 P C ae C36 :3 PC a e C4 4:4 PC a a C 3 2:0 PC aa C4 0: 3 P C ae C36 :4 PC a e C4 4:5 PC a a C 3 2:1 PC aa C4 0: 4 P C ae C36 :5 PC a e C4 4:6 Table S1 -Plasma concentration (µM) of quantified metabolites at day 1 for each patient. Survival status at 28 days and 90 days is also reported (S, survivor; NS, non survivor). #1  #2  #3  #4  #5  #6  #7  #8  #9  #10  #11  #12  #13  #14  #15  #16  #17  #18  #19  #20   28 day survival  S  S  NS  NS  NS  NS  S  S  S  S  NS  NS  S  S  S  NS  NS  S  NS  S   90 day survival  NS  S  NS  NS  NS  NS  S  NS  S  S  NS  NS  S  S  S  NS  NS  S 
Metabolite D1
